Delivery Order SPE2DB20D3101-SPE2DB23FQXD9
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,435.54 fixed-price contract is for the delivery of Isentress 400 mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,905.63 firm fixed-price contract is for the delivery of Isentress 400 mg tablets, a prescription medication used to treat HIV infection. The contract has a period of performance through February 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,061.39 contract is for the delivery of Isentress 400 mg tablets, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,288.10, is for the provision of the HIV treatment medication ISENTRESS 400 MG TABLET 60S. This delivery order contract falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The $6,230.85 firm-fixed-price contract has an ultimate completion date of March 28, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,142.48, is for the delivery of Isentress 400 mg tablets. The contract has an ultimate completion date of July 22, 2024 and is a firm fixed-price delivery order. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Isentress 400 mg tablets. The contract has a ceiling value of $3,555.72 and an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,394.57, is for the delivery of Isentress 400 mg tablets, a medication used in the treatment of HIV/AIDS. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Isentress 400 mg tablets, a prescription antiretroviral medication. The contract has a ceiling value of $1,185.24 and an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,668.50, is for the delivery of Isentress 400 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of December 12, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FQXD9Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $1,967.66, is for the delivery of Isentress 400 mg tablets, a medication used to treat HIV infection. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is part of that larger IDC, demonstrating Amerisourcebergen's capacity to efficiently fulfill the government's diverse and critical pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/12/22 |